VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $184,078,000 | -0.3% | 1,031,942 | +24.1% | 2.51% | -4.0% |
| Q2 2015 | $184,699,000 | +10009.4% | 831,417 | +8937.1% | 2.62% | +9596.3% |
| Q1 2015 | $1,827,000 | -82.8% | 9,200 | -87.6% | 0.03% | -82.0% |
| Q4 2014 | $10,616,000 | -9.9% | 74,176 | -20.6% | 0.15% | -18.0% |
| Q2 2014 | $11,783,000 | -94.8% | 93,427 | -94.5% | 0.18% | -95.0% |
| Q1 2014 | $225,658,000 | +150.6% | 1,711,727 | +123.2% | 3.65% | +106.7% |
| Q4 2013 | $90,042,000 | -32.0% | 766,970 | -50.2% | 1.77% | -42.9% |
| Q2 2013 | $132,480,000 | – | 1,539,019 | – | 3.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |